163 related articles for article (PubMed ID: 9863878)
1. Detection of HIV-1 nucleic acid and HIV-1 antibodies in needles and syringes used for non-intravenous injection.
Rich JD; Dickinson BP; Carney JM; Fisher A; Heimer R
AIDS; 1998 Dec; 12(17):2345-50. PubMed ID: 9863878
[TBL] [Abstract][Full Text] [Related]
2. Potential for HIV transmission through unsafe injections.
Apetrei C; Becker J; Metzger M; Gautam R; Engle J; Wales AK; Eyong M; Enyong P; Sama M; Foley BT; Drucker E; Marx PA
AIDS; 2006 Apr; 20(7):1074-6. PubMed ID: 16603865
[TBL] [Abstract][Full Text] [Related]
3. Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.
Abdala N; Patel A; Heimer R
AIDS Res Hum Retroviruses; 2016; 32(10-11):947-954. PubMed ID: 27548374
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 RNA load in needles/syringes from shooting galleries in Miami: a preliminary laboratory report.
Shapshak P; Fujimura RK; Page JB; Segal D; Rivers JE; Yang J; Shah SM; Graham G; Metsch L; Weatherby N; Chitwood DD; McCoy CB
Drug Alcohol Depend; 2000 Feb; 58(1-2):153-7. PubMed ID: 10669066
[TBL] [Abstract][Full Text] [Related]
5. Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
Shah SM; Shapshak P; Rivers JE; Stewart RV; Weatherby NL; Xin KQ; Page JB; Chitwood DD; Mash DC; Vlahov D; McCoy CB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Mar; 11(3):301-6. PubMed ID: 8603266
[TBL] [Abstract][Full Text] [Related]
6. HIV DNA and antibodies in syringes from injecting drug users: a comparison of detection techniques.
Myers SS; Heimer R; Liu D; Henrard D
AIDS; 1993 Jul; 7(7):925-31. PubMed ID: 8357554
[TBL] [Abstract][Full Text] [Related]
7. Needle exchange decreases the prevalence of HIV-1 proviral DNA in returned syringes in New Haven, Connecticut.
Heimer R; Kaplan EH; Khoshnood K; Jariwala B; Cadman EC
Am J Med; 1993 Aug; 95(2):214-20. PubMed ID: 8356986
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis in used syringes: the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens.
Heimer R; Khoshnood K; Jariwala-Freeman B; Duncan B; Harima Y
J Infect Dis; 1996 Apr; 173(4):997-1000. PubMed ID: 8603983
[TBL] [Abstract][Full Text] [Related]
9. Syringe HIV seroprevalence and behavioural and demographic characteristics of intravenous drug users in Sydney, Australia, 1987.
Wolk J; Wodak A; Morlet A; Guinan JJ; Wilson E; Gold J; Cooper DA
AIDS; 1988 Oct; 2(5):373-7. PubMed ID: 3146266
[TBL] [Abstract][Full Text] [Related]
10. Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania.
Hoelscher M; Riedner G; Hemed Y; Wagner HU; Korte R; von Sonnenburg F
AIDS; 1994 Nov; 8(11):1609-15. PubMed ID: 7848599
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers.
Wodak A; Dolan K; Imrie AA; Gold J; Wolk J; Whyte BM; Cooper DA
Med J Aust; 1987 Sep; 147(6):275-6. PubMed ID: 3650679
[TBL] [Abstract][Full Text] [Related]
12. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
Steinglass R; Boyd D; Grabowsky M; Laghari AG; Khan MA; Qavi A; Evans P
Bull World Health Organ; 1995; 73(1):57-63. PubMed ID: 7704926
[TBL] [Abstract][Full Text] [Related]
13. Effects of varying concentrations of bleach on in vitro HIV-1 replication and the relevance to injection drug use.
Contoreggi C; Jones S; Simpson P; Lange WR; Meyer WA
Intervirology; 2000; 43(1):1-5. PubMed ID: 10773730
[TBL] [Abstract][Full Text] [Related]
14. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa.
Ekwueme DU; Weniger BG; Chen RT
Bull World Health Organ; 2002; 80(11):859-70. PubMed ID: 12481207
[TBL] [Abstract][Full Text] [Related]
15. Quantification of HIV-1 viral RNA in the blood in needles used for venous puncture in HIV-infected individuals.
Rossin IR; Machado AA; Junqueira ÉM; Martinez R
Rev Soc Bras Med Trop; 2011; 44(6):661-4. PubMed ID: 22231239
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model.
Rao SS; Gomez P; Mascola JR; Dang V; Krivulka GR; Yu F; Lord CI; Shen L; Bailer R; Nabel GJ; Letvin NL
Vaccine; 2006 Jan; 24(3):367-73. PubMed ID: 16194587
[TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial to assess pain and bruising in medicines administered by means of subcutaneous and intramuscular needle injection: is it necessary to have needles changed?
Lamblet LC; Meira ES; Torres S; Ferreira BC; Martucchi SD
Rev Lat Am Enfermagem; 2011; 19(5):1063-71. PubMed ID: 22030569
[TBL] [Abstract][Full Text] [Related]
18. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
[TBL] [Abstract][Full Text] [Related]
19. Detection of HIV, hepatitis B and hepatitis C markers in discarded syringes and bloodstains.
Cattaneo C; Nuttall PA; Sokol RJ
Sci Justice; 1996; 36(4):271-4. PubMed ID: 8921748
[TBL] [Abstract][Full Text] [Related]
20. Rapid assessment of injection practices in Cambodia, 2002.
Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
